Karol Polom1, Daniele Marrelli2, Valeria Pascale2, Giandomenico Roviello3, Costantino Voglino2, Henry Rho4, Carla Vindigni5, Mario Marini6, Raffaele Macchiarelli6, Franco Roviello2. 1. General Surgery and Surgical Oncology Department, University of Siena, viale Bracci 16, 53-100, Siena, Italy. polom.karol@gmail.com. 2. General Surgery and Surgical Oncology Department, University of Siena, viale Bracci 16, 53-100, Siena, Italy. 3. Section of Pharmacology and University Center DIFF-Drug Innovation Forward Future, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 4. University of Medical Sciences, Poznan, Poland. 5. Department of Pathology, Azienda Ospedaliera Universitaria Senese, Siena, Italy. 6. Department of Medicine, Surgery and Neurosciences, Unit of Endoscopy and Gastroenterology, University of Siena, Siena, Italy.
Abstract
PURPOSE: The different pathological characteristics and prognoses between gastric cancer patients coming from high-risk (group A) and low-risk (group B) areas of Italy were analyzed. We investigated a suspected difference in microsatellite instability (MSI) between these two groups. METHODS: MSI analyses of 452 gastric cancer patients were performed using five quasimonomorphic mononucleotide repeats NR-21, NR-24, NR-27, BAT-25, and BAT-26. MSI analysis was done by PCR usage. An allelic profile of these five mononucleotides was detected on an automated DNA sequencer ABI PRISM 3100 Genetic Analyser. Data were analyzed according to high-risk and low-risk gastric cancer areas. RESULTS: MSI was observed in 23.9 % of all gastric cancer patients studied. Patients from group A showed a higher rate of MSI (28.4 %) than from group B (13.5 %) (p < 0.001). We analyzed this association together with tumor location and Lauren classification: A nonsignificant differences were seen when analyzing cardia and non-cardia tumors (p = 0.854) but significant for Lauren histotype (p = 0.028). There was no statistical difference in survival between high-risk and low-risk areas (p = 0.437), with a nonsignificant trend for better survival in the high-risk group, especially when measured over a longer period of time. Analyzing MSI or MSS in these groups, the survival curves were almost the same. CONCLUSIONS: A higher frequency of MSI in patients coming from high-risk areas may help explain geographical differences in gastric cancer. The trend of better survival in high-risk areas may be due to a higher rate of MSI gastric cancer patients.
PURPOSE: The different pathological characteristics and prognoses between gastric cancerpatients coming from high-risk (group A) and low-risk (group B) areas of Italy were analyzed. We investigated a suspected difference in microsatellite instability (MSI) between these two groups. METHODS: MSI analyses of 452 gastric cancerpatients were performed using five quasimonomorphic mononucleotide repeats NR-21, NR-24, NR-27, BAT-25, and BAT-26. MSI analysis was done by PCR usage. An allelic profile of these five mononucleotides was detected on an automated DNA sequencer ABI PRISM 3100 Genetic Analyser. Data were analyzed according to high-risk and low-risk gastric cancer areas. RESULTS: MSI was observed in 23.9 % of all gastric cancerpatients studied. Patients from group A showed a higher rate of MSI (28.4 %) than from group B (13.5 %) (p < 0.001). We analyzed this association together with tumor location and Lauren classification: A nonsignificant differences were seen when analyzing cardia and non-cardia tumors (p = 0.854) but significant for Lauren histotype (p = 0.028). There was no statistical difference in survival between high-risk and low-risk areas (p = 0.437), with a nonsignificant trend for better survival in the high-risk group, especially when measured over a longer period of time. Analyzing MSI or MSS in these groups, the survival curves were almost the same. CONCLUSIONS: A higher frequency of MSI in patients coming from high-risk areas may help explain geographical differences in gastric cancer. The trend of better survival in high-risk areas may be due to a higher rate of MSI gastric cancerpatients.
Entities:
Keywords:
Cancer risk; Gastric cancer; Microsatellite instability; Molecular
Authors: James C Yao; Jennifer F Tseng; Samidha Worah; Kenneth R Hess; Paul F Mansfield; Christopher H Crane; Isac I Schnirer; Satish Reddy; Silvia S Chiang; Azmeena Najam; Christina Yu; Geoffrey G Giacco; Keping Xie; Tsung-Teh Wu; Barry W Feig; Peter W T Pisters; Jaffer A Ajani Journal: J Clin Oncol Date: 2005-05-01 Impact factor: 44.544
Authors: D Palli; A Russo; L Ottini; G Masala; C Saieva; A Amorosi; A Cama; C D'Amico; M Falchetti; R Palmirotta; A Decarli; R Mariani Costantini; J F Fraumeni Journal: Cancer Res Date: 2001-07-15 Impact factor: 12.701
Authors: A M Chiaravalli; D Furlan; C Facco; M G Tibiletti; A Dionigi; B Casati; L Albarello; C Riva; C Capella Journal: Virchows Arch Date: 2001-01 Impact factor: 4.064
Authors: E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert Journal: Cancer Date: 1993-05-15 Impact factor: 6.860
Authors: Jung Ho Shim; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park; Lindsay M Jacks; Mithat Gonen; Manish A Shah; Murray F Brennan; Daniel G Coit; Vivian E Strong Journal: Ann Surg Oncol Date: 2014-03-06 Impact factor: 5.344
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396